about
Subunit composition of ATP-sensitive potassium channels in mitochondria of rat heartsMembranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis.Perspectives in tissue microarrays.Transfer and multiplex immunoblotting of a paraffin embedded tissue.Optimization of recovery of RNA from formalin-fixed, paraffin-embedded tissue.Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma.Assessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein arraySynaptonemal complex protein 3 is a prognostic marker in cervical cancer.A well-based reverse-phase protein array applicable to extracts from formalin-fixed paraffin-embedded tissue.Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer.HER-2 assessment in formalin-fixed paraffin-embedded breast cancer tissue by well-based reverse phase protein arrayFactors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections.A well-based reverse-phase protein array of formalin-fixed paraffin-embedded tissue.Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesisA pressure cooking-based DNA extraction from archival formalin-fixed, paraffin-embedded tissue.Computational analysis of the mesenchymal signature landscape in gliomas.Nanog signaling in cancer promotes stem-like phenotype and immune evasionModification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.Experimental murine fascioliasis derives early immune suppression with increased levels of TGF-β and IL-4.Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer.A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patientsTissue microarrays enabling high-throughput molecular pathology.Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular ApplicationsAccumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancerAPI5 confers cancer stem cell-like properties through the FGF2-NANOG axis.Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.Histo-proteomic profiling of formalin-fixed, paraffin-embedded tissue.Profiling of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small cell lung cancer.REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survivalEpidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion.Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue.The anti-cancer effects of itraconazole in epithelial ovarian cancerPancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients.
P50
Q28568721-54AE4CB9-3C25-4775-963F-F4979744E7FFQ30430971-ED52616C-4B89-478B-A7BE-5C5523AC0559Q30491274-F8924BA6-0646-412C-9219-98E7C35839C4Q30768875-C456B476-84E6-4844-BE8A-133A0E72BCD6Q31114058-E24B9DBE-0108-4E82-8B47-3FA94B08AD62Q33231137-59F7AACE-A673-4D1F-BB51-64D2A3D4B6B3Q33264450-7527B884-3BF8-44BF-AA8C-792F9BD9AC5DQ33571893-905BB084-EC16-40A8-88F6-A6AC9CE17EB2Q33688120-52199E56-CCC8-487D-A4B0-68E50BD09B2BQ33721741-9B6DB717-3F0D-4130-AE73-A3BF82BA7493Q33764388-476F1EB8-7910-4430-9A32-CF4F1AE93002Q35169206-C8509831-7C2B-4863-B4D2-073BDA2A321DQ35184966-D1B44DD3-D335-4854-B38C-F22F8911083CQ35440862-C5724387-4EEE-4873-B2FD-294A0EC8077BQ35653193-9D0F3BDE-4311-4728-BB7C-8EDDFFEE7976Q35659259-03808568-84F8-4C45-B00B-44F8B7A69EB9Q35878793-6FC6C84D-083C-4108-A97A-1421E10662E6Q35898353-0F0B6094-9C70-40C7-9F8F-0D25B304A1C0Q35983175-7B66A1F9-5537-4B68-A1F0-6CF3C4A5F226Q36303247-1417E7B8-97F1-4AF8-A7C4-E1AAAF2A0088Q36357895-38F44448-B06C-4203-B63D-3B826D047E97Q36361883-C3A731B3-DCE1-4715-B5A5-F4D93E54EB5BQ36445311-B9E62751-F71A-4F75-A287-0743D2CC2EE3Q36545001-6F0C8633-EAC2-4DD8-A642-B0393A9348BFQ36584742-13731712-F544-4037-96F1-2E7A8D0DC82CQ36879739-F30E5273-8873-4BBE-8901-292CE108995BQ36887598-795DFCD9-DBF8-4FD1-B106-FABC048FA01BQ37038009-ECD30330-66EE-4809-839F-A16FB07C764EQ37062250-651BC469-A12F-4584-BDE4-353CE52CBE63Q37580261-DB7C329B-4F13-4371-8EC6-925B58FB1BCCQ37627441-F1381A14-7CD1-4BB6-987F-7A90A179DF49Q37684607-9F69D6E3-D544-4579-BC6B-E03A42B89684Q37727189-5A470623-8BFB-471C-AEFD-345528A6856EQ37733727-E217134F-2F9F-4043-AD32-6D574F750450Q37744916-88BCBA94-D5A2-4594-81CF-4A9061E67519Q38339611-889127E0-5C84-431E-93B4-B21E76D54599Q38373772-10E3EB34-C89A-40CF-A9EF-1CFE289486D8Q38378699-A07BD015-D8C9-44FD-AD8B-DD840386A3E9Q38696316-60F96CB6-B03C-4FE2-838D-C81C78299EF3Q38887690-F83F900E-E011-4B27-B62E-0EC387485302
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joon-Yong Chung
@ast
Joon-Yong Chung
@en
Joon-Yong Chung
@es
Joon-Yong Chung
@nl
Joon-Yong Chung
@sl
type
label
Joon-Yong Chung
@ast
Joon-Yong Chung
@en
Joon-Yong Chung
@es
Joon-Yong Chung
@nl
Joon-Yong Chung
@sl
prefLabel
Joon-Yong Chung
@ast
Joon-Yong Chung
@en
Joon-Yong Chung
@es
Joon-Yong Chung
@nl
Joon-Yong Chung
@sl
P1153
P1053
J-9177-2017
P106
P1153
57194076119
57195950639
7404002468
P2798
P31
P3829
P3835
joon-yong-chung
P496
0000-0001-5041-5982